Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort

A significant change has occurred over time in vascular medication use in SSc patients, with increased utilization of ERA, PDE5i, CCB and anti-platelet therapies suggesting the adoption of more proactive and/or preventive treatment strategies.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2025-06-03
DOI
https://doi.org/10.1093/rheumatology/keaf290
Citations
4
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
5.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort

Kristofer Andréasson, Otylia Kowal Bielecka, Gonçalo Boleto, Luc Mouthon et al.
4 citations
Lara D. Veeken
Systemic Sclerosis and Related Diseases
5.89
article

Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort

Kristofer Andréasson, Otylia Kowal Bielecka, Gonçalo Boleto, Luc Mouthon, Ulrich A. Walker, Michael Hughes, Marco Di Battista, L. P. Ananyeva, Tim Schmeiser, G. Szücs, David Launay, Florenzo Iannone, Alexandra Balbir‐Gurman, Michele Iudici, Dominique Farge Bancel, Kastriot Kastrati, Francesco Paolo Cantatore, Carlomaurizio Montecucco, Vanessa Smith, Maurizio Cutolo, Gianluca Moroncini, Andra Rodica Balanescu, Kamal Solanki, Edward Bernard Jude, Katja Perdan Pirkmajer, Marco Matucci‐Cerinic, Marie‐Elise Truchetet, Sheila Ramjug, Jeska de Vries‐Bouwstra, Carolina de Souza Müller, Serena Guiducci, Simona Rednic, Nicolas Hunzelmann, Madelon C Vonk, Yannick Allanore, Patricia E. Carreira, Bernard Coleiro, Stefano Di Donato, Massimiliano Limonta, Silvia Bellando-Randone, Elise Siegert, Luca Idolazzi, Valeria Riccieri, Esthela Loyo, Daniel E. Furst, Oliver Distler, Camillo Ribi, Francesco Del Galdo, Radim Bečvář, Rossella Talotta, Maria De Santis, Masataka Kuwana, Masato Okada, Mislav Radić, Eduardo Kerzberg, Jérôme Avouac, Marija Geroldinger‐Simić, Vasiliki Liakouli, John D Pauling, Elisabetta Zanatta, Thierry Martin, Martin Aringer, José António Pereira da Silva, T. Soukup, Lesley Ann Saketkoo, Yasushi Kawaguchi, Mohammad Naffaa, Lidia P Ananieva, László Czirják, Paolo Airó, Maria Rosa Pozzi, Yair Levy, Maura Couto, Vahan Mukuchyan, Len Harty, Masataka Kuwana, Iwata Futoshi, Rosario Foti, Figen Yargucu Zhini
article en
4 citations

Abstract

A significant change has occurred over time in vascular medication use in SSc patients, with increased utilization of ERA, PDE5i, CCB and anti-platelet therapies suggesting the adoption of more proactive and/or preventive treatment strategies.

Lara D. VeekenVol. 64(10)
University of Foggia (IT), University of Pisa (IT), Marche Polytechnic University (IT), Centre National de la Recherche Scientifique (FR), North Bristol NHS Trust (GB), University of Leeds (GB), University of Padua (IT), University of Lisbon (PT), Radboud University Nijmegen (NL), Université de Bordeaux (FR), Vita-Salute San Raffaele University (IT), Carol Davila University of Medicine and Pharmacy (RO), Université Paris Cité (FR), Leeds Teaching Hospitals NHS Trust (GB), Manchester Academic Health Science Centre (GB), Radboud University Medical Center (NL), University of Manchester (GB), Research Institute Hospital 12 de Octubre (ES), Sorbonne Paris Cité (FR), Hôpital Cochin (FR), Instituto de Medicina Tropical (PY), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), ENT and Allergy (US), Tameside and Glossop Integrated Care NHS Foundation Trust (GB), Administração Regional de Saúde de Lisboa e Vale do Tejo (PT), Immunology from Concept and Experiments to Translation (FR), NIHR Leeds Musculoskeletal Biomedical Research Unit (GB), Association of Rheumatologists of Russia (RU), Centre Inria de l'université de Bordeaux (FR), IRCCS Ospedale San Raffaele (IT), Hospital de Santa Maria (PT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), Universidade Federal do Paraná (BR), Diabetes UK (GB), Nippon Medical School (JP)
Good health and well-being
Openalex Percentile: Top 4%
Systemic Sclerosis and Related Diseases
5.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.